2024年5月15日 · One Japanese encephalitis vaccine (called IXIARO) is available in the United States. Japanese encephalitis vaccine is approved for use in children aged 2 months and older and adults. The vaccine should be considered for some travelers at higher risk of …

Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. [2] The vaccines are more than 90% effective. [2] The duration of protection with the vaccine is not clear but its effectiveness appears to decrease over time. [2] Doses are given either by injection into a muscle or just under the skin. [2]

2024年5月15日 · One inactivated Japanese encephalitis (JE) vaccine (manufactured as IXIARO) is available in the United States. JE vaccine is approved for use in children aged 2 months and older and adults. JE is a very low risk disease for most travelers.

2019年8月15日 · JE vaccine. Japanese encephalitis vaccine is approved for people 2 months of age and older. It is recommended for people who: Plan to live in a country where JE occurs. Plan to visit a country where JE occurs for long periods (e.g., one month or more). Frequently travel to countries where JE occurs.

The JEV vaccine prevents Japanese encephalitis virus infections. This infection results from a mosquito bite. Your provider may recommend this vaccine if you’re traveling to Asia or the western Pacific, and plan to stay for more than four weeks.

Vaccination of humans is the most effective means of preventing JE. There are three types of inactivated vaccines and one type of live attenuated vaccine currently used in the world: Vero-cell derived purified vaccine based on the P-1, P-3 or SA14-14-2 strains as virus seeds.;

The Japanese encephalitis vaccine prevents Japanese encephalitis infections. This infection causes fever, headaches and neck pain. It can also affect cognitive functioning, leading to confusion and behavior changes.